![]() |
Page 1PATIENT INFORMATIONJANE DOE Age: 21 years |
||||||||||
PHYSICIANJOHN SMITH, M.D 1234 JOHN WAY CC: JACK SMITH M.D.
|
SPECIMEN INFORMATION
|
||||||||||
HISTORY |
MATURATION INDEX |
SPECIMEN SOURCE: CERVICAL/VAGINAL/1 THINPREP/1 ONESWAB Slide |
ESTROGEN EFFECT (HORMONAL PATTERN): COMPATIBLE WITH AGE AND/OR HISTORY. |
| PAP TEST RESULTS WITH IMAGER | Date Reported: 2/12/2008 |
NEGATIVE for intraepithelial lesion or malignancy. Endocervical cells or associated benign metaplastic cells present. Negative for trichomonads and candida.
Management Recommendation: Cytology Negative, HPV Negative: Routine Screening at clinically appropriate interval, as suggested by the Consensus Workshop or at three years. (Obstetrics and Gynecology 2004;103:302-309)
Pathologist: WAYNE L. GARRETT, D.O.
| CHLAMYDIA/GONORRHEA TEST RESULTS BY PCR | Date Reported: 2/7/2008 |
| Chlamydia | Negative |
| Gonorrhea | Negative |
Pathologist: JOHN COMPAGNO, M.D., MEDICAL DIRECTOR
| GROUP B STREPTOCOCCUS BY RT-PCR | Date Reported: 2/11/2008 |
Group B Streptococcus: Positive Group B streptococcus has been detected in this patient by RT-PCR suggesting vaginal and/or rectal group B streptococcus colonization. Please refer to CDC revised complete guidelines for prevention of perinatal Group B Streptococcal disease. (CDC MMWR Aug 16, 2002/Vol51/No.RR-11).
Pathologist: JOHN COMPAGNO, M.D., MEDICAL DIRECTOR
This test was developed and its performance characteristics determined by Medical Diagnostic Laboratories, LLC, 2439 Kuser Road, Hamilton, NJ 08690. It has not been cleared or approved by the U.S. Food and Drug Administration. The FDA has determined that such clearance or approval is not necessary.
Note: For DNA Tests Supporting Documentation, see http://www.wcpl.com/dna_support_doc.asp |
Note: The following tests are available for 60 days post collection if specimen submitted as a ThinPrep®. Please call (800) 794-9737 for additional testing, if desired.
